Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 3
2014 5
2015 6
2016 3
2017 5
2018 15
2019 40
2020 36
2021 23
2022 23
2023 23
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

150 results

Results by year

Filters applied: . Clear all
Page 1
Radiomics in prostate cancer: an up-to-date review.
Ferro M, de Cobelli O, Musi G, Del Giudice F, Carrieri G, Busetto GM, Falagario UG, Sciarra A, Maggi M, Crocetto F, Barone B, Caputo VF, Marchioni M, Lucarelli G, Imbimbo C, Mistretta FA, Luzzago S, Vartolomei MD, Cormio L, Autorino R, Tătaru OS. Ferro M, et al. Among authors: mistretta fa. Ther Adv Urol. 2022 Jul 4;14:17562872221109020. doi: 10.1177/17562872221109020. eCollection 2022 Jan-Dec. Ther Adv Urol. 2022. PMID: 35814914 Free PMC article. Review.
Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review.
Ferro M, Crocetto F, Barone B, Del Giudice F, Maggi M, Lucarelli G, Busetto GM, Autorino R, Marchioni M, Cantiello F, Crocerossa F, Luzzago S, Piccinelli M, Mistretta FA, Tozzi M, Schips L, Falagario UG, Veccia A, Vartolomei MD, Musi G, de Cobelli O, Montanari E, Tătaru OS. Ferro M, et al. Among authors: mistretta fa. Ther Adv Urol. 2023 Apr 17;15:17562872231164803. doi: 10.1177/17562872231164803. eCollection 2023 Jan-Dec. Ther Adv Urol. 2023. PMID: 37113657 Free PMC article. Review.
Therapeutic Sequences in the Treatment of High-Risk Prostate Cancer: Paving the Way Towards Multimodal Tailored Approaches.
Marvaso G, Corrao G, Zaffaroni M, Pepa M, Augugliaro M, Volpe S, Musi G, Luzzago S, Mistretta FA, Verri E, Cossu Rocca M, Ferro M, Petralia G, Nolè F, De Cobelli O, Orecchia R, Jereczek-Fossa BA. Marvaso G, et al. Among authors: mistretta fa. Front Oncol. 2021 Aug 4;11:732766. doi: 10.3389/fonc.2021.732766. eCollection 2021. Front Oncol. 2021. PMID: 34422672 Free PMC article. Review.
Artificial Intelligence in the Advanced Diagnosis of Bladder Cancer-Comprehensive Literature Review and Future Advancement.
Ferro M, Falagario UG, Barone B, Maggi M, Crocetto F, Busetto GM, Giudice FD, Terracciano D, Lucarelli G, Lasorsa F, Catellani M, Brescia A, Mistretta FA, Luzzago S, Piccinelli ML, Vartolomei MD, Jereczek-Fossa BA, Musi G, Montanari E, Cobelli O, Tataru OS. Ferro M, et al. Among authors: mistretta fa. Diagnostics (Basel). 2023 Jul 7;13(13):2308. doi: 10.3390/diagnostics13132308. Diagnostics (Basel). 2023. PMID: 37443700 Free PMC article. Review.
Multiparametric MRI-based 5-year Risk Prediction Model for Biochemical Recurrence of Prostate Cancer after Radical Prostatectomy.
Luzzago S, Colombo A, Mistretta FA, Alessi S, Di Trapani E, Summers PE, Piccinelli ML, Raimondi S, Vignati S, Clemente A, Rosati E, di Meglio L, d'Ascoli E, Scarabelli A, Zugni F, Belmonte M, Maggioni R, Ferro M, Fusco N, de Cobelli O, Musi G, Petralia G. Luzzago S, et al. Among authors: mistretta fa. Radiology. 2023 Nov;309(2):e223349. doi: 10.1148/radiol.223349. Radiology. 2023. PMID: 37987657
150 results